Friday, SAB Biotherapeutics, Inc. (SABS) announced that Samuel Reich, who currently serves as the executive chairman, will take on the additional role of chief executive officer of the company effective immediately.
Reich's journey with SAB started in 2021 when he became the Executive Chairman, following the merger with Big Cypress Acquisition Group. Previously, he had held various senior-level positions at Big Cypress, including Chief Executive Officer and Chief Financial Officer.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.